[Palliative treatment of metastatic liver cancer and physiopathological observations].
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001663:Bilirubin / Q000032:analysis; D001798:Blood Proteins / Q000032:analysis; D005706:Gallbladder Neoplasms / Q000150:complications; D006499:Hepatic Artery / Q000601:surgery; D006801:Humans; D007263:Infusions, Parenteral; D007414:Intestinal Neoplasms / Q000150:complications; D008113:Liver Neoplasms / Q000188:drug therapy / Q000503:physiopathology / Q000601:surgery / Q000628:therapy*; D008722:Methods; D009362:Neoplasm Metastasis / Q000503:physiopathology / Q000628:therapy; D009369:Neoplasms; D010166:Palliative Care; D051381:Rats; D012709:Serum Albumin / Q000627:therapeutic use; D013274:Stomach Neoplasms / Q000150:complications
D000970:Antineoplastic Agents; D001798:Blood Proteins; D012709:Serum Albumin; D001663:Bilirubin
Palliative Behandlung von metastatischem Leberkrebs und pathophysiologische Bemerkungen.